Zurich Cantonal Bank’s Albireo Pharma Inc ALBO Stock Holding History

Zurich Cantonal Bank’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,713	Closed	-$123K	–	2895
2022 Q4	$123K	Buy	5,713 +813	+17%	+$17.2K	﹤0.01%	2145
2022 Q3	$95K	Hold	4,900	–	–	﹤0.01%	2268
2022 Q2	$97K	Hold	4,900	–	–	﹤0.01%	2271
2022 Q1	$146K	Hold	4,900	–	–	﹤0.01%	2089
2021 Q4	$114K	Buy	+4,900	New	+$130K	﹤0.01%	2435

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Zurich Cantonal Bank's ALBO Position: Q1 2023 in Review

Zurich Cantonal Bank sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 5,713 shares — an estimated $123K sold.

Zurich Cantonal Bank first reported a position in ALBO in Q4 2021 and held it in 5 quarters. The position peaked at $146K in Q1 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Zurich Cantonal Bank reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Zurich Cantonal Bank sold 5,713 Albireo Pharma Inc shares in Q1 2023, an estimated $123K.
Zurich Cantonal Bank first reported a position in Albireo Pharma Inc in Q4 2021 and held it in 5 quarters.
Zurich Cantonal Bank's Albireo Pharma Inc position peaked at $146K in Q1 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Zurich Cantonal Bank's 13F filing for Q1 2023, filed 8 May 2023.